AR Asset Management’s AstraZeneca AZN Stock Holding History

AR Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$758K	Hold	4,000	–	–	0.14%	95
2026 Q1	$789K	Hold	4,000	–	–	0.15%	85
2025 Q4	$735K	Hold	4,000	–	–	0.15%	90
2025 Q3	$614K	Hold	4,000	–	–	0.13%	94
2025 Q2	$559K	Hold	4,000	–	–	0.12%	94
2025 Q1	$588K	Hold	4,000	–	–	0.13%	92
2024 Q4	$524K	Hold	4,000	–	–	0.12%	91
2024 Q3	$623K	Hold	4,000	–	–	0.14%	88
2024 Q2	$624K	Hold	4,000	–	–	0.15%	85
2024 Q1	$542K	Hold	4,000	–	–	0.13%	90
2023 Q4	$539K	Hold	4,000	–	–	0.14%	87
2023 Q3	$542K	Hold	4,000	–	–	0.15%	83
2023 Q2	$573K	Hold	4,000	–	–	0.15%	83
2023 Q1	$555K	Hold	4,000	–	–	0.15%	88
2022 Q4	$542K	Hold	4,000	–	–	0.15%	85
2022 Q3	$439K	Hold	4,000	–	–	0.13%	94
2022 Q2	$529K	Hold	4,000	–	–	0.15%	91
2022 Q1	$531K	Hold	4,000	–	–	0.13%	94
2021 Q4	$466K	Hold	4,000	–	–	0.12%	98
2021 Q3	$480K	Hold	4,000	–	–	0.13%	95
2021 Q2	$479K	Hold	4,000	–	–	0.13%	95
2021 Q1	$398K	Hold	4,000	–	–	0.12%	99
2020 Q4	$400K	Hold	4,000	–	–	0.13%	96
2020 Q3	$438K	Hold	4,000	–	–	0.15%	94
2020 Q2	$423K	Hold	4,000	–	–	0.16%	95
2020 Q1	$357K	Hold	4,000	–	–	0.15%	98
2019 Q4	$399K	Hold	4,000	–	–	0.13%	99
2019 Q3	$357K	Hold	4,000	–	–	0.13%	101
2019 Q2	$330K	Hold	4,000	–	–	0.12%	105
2019 Q1	$323K	Hold	4,000	–	–	0.12%	105
2018 Q4	$304K	Hold	4,000	–	–	0.13%	101
2018 Q3	$317K	Hold	4,000	–	–	0.12%	106
2018 Q2	$281K	Hold	4,000	–	–	0.11%	108
2018 Q1	$280K	Hold	4,000	–	–	0.11%	105
2017 Q4	$278K	Hold	4,000	–	–	0.11%	109
2017 Q3	$271K	Hold	4,000	–	–	0.11%	113
2017 Q2	$273K	Hold	4,000	–	–	0.11%	112
2017 Q1	$249K	Hold	4,000	–	–	0.1%	113
2016 Q4	$219K	Hold	4,000	–	–	0.09%	116
2016 Q3	$263K	Hold	4,000	–	–	0.11%	109
2016 Q2	$242K	Hold	4,000	–	–	0.1%	111
2016 Q1	$225K	Hold	4,000	–	–	0.1%	113
2015 Q4	$272K	Hold	4,000	–	–	0.12%	105
2015 Q3	$255K	Hold	4,000	–	–	0.11%	109
2015 Q2	$255K	Hold	4,000	–	–	0.1%	105
2015 Q1	$274K	Hold	4,000	–	–	0.11%	102
2014 Q4	$282K	Hold	4,000	–	–	0.11%	101
2014 Q3	$286K	Hold	4,000	–	–	0.12%	102
2014 Q2	$297K	Hold	4,000	–	–	0.12%	101
2014 Q1	$260K	Hold	4,000	–	–	0.11%	104
2013 Q4	$237K	Hold	4,000	–	–	0.1%	103
2013 Q3	$208K	Buy	+4,000	New	+$201K	0.09%	108

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AR Asset Management's AZN Position: Q2 2026 in Review

AR Asset Management held its AstraZeneca (AZN) position steady in Q2 2026 at 4,000 shares worth $758K. The position accounts for 0.14% of the portfolio, ranked #95.

AR Asset Management first reported a position in AZN in Q3 2013 and has held it in 52 quarters since. The position peaked at $789K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

AR Asset Management held 4,000 shares of AstraZeneca worth $758K as of Q2 2026.
AR Asset Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.14% of AR Asset Management's portfolio in Q2 2026, its #95 holding.
AR Asset Management first reported a position in AstraZeneca in Q3 2013 and has held it in 52 quarters since.
AR Asset Management's AstraZeneca position peaked at $789K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AR Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.